Clinical application and progress of yttrium 90 microsphere selective internal radiation therapy in primary hepatic cancer
10.3760/cma.j.cn115610-20231208-00242
- VernacularTitle:钇-90微球选择性内放射治疗在原发性肝癌中的临床应用及进展
- Author:
Hui ZHANG
1
;
Ying FU
;
Binbin TAN
;
Minghua SHAO
;
Ping LIU
;
Chao FAN
;
Hailei CHEN
;
Zhiyu CHEN
Author Information
1. 陆军军医大学第一附属医院肝胆外科，重庆 400038
- Keywords:
Liver neoplasms;
Yttrium-90;
Selective internal radiotherapy;
Research progress
- From:
Chinese Journal of Digestive Surgery
2024;23(2):242-247
- CountryChina
- Language:Chinese
-
Abstract:
Primary hepatic cancer is one of the major problems that need to be solved urgently in the field of public health, seriously endangering the life and health of Chinese people. Its treatment mode is multidisciplinary participation and synergy of multiple therapeutic methods. Even though there are many common clinical treatments for liver cancer in China, its therapeutic outcome is still unsatisfactory. yttrium-90 has been applied for more than 20 years, and a large amount of foreign clinical data have been accumulated. Combining the latest literature and clinical practice, the authors describe the clinical application and research progress of yttrium-90 micro-sphere selective internal radiation therapy in primary liver cancer.
